Submission for Review: Survey on the Treatment of Opioid Use Disorders; Correction, 71004-71005 [2019-27708]
Download as PDF
<![CDATA[
71004
Federal Register / Vol. 84, No. 247 / Thursday, December 26, 2019 / Notices
copies of the information collection
instrument(s) and instructions should
be directed to Claire Little, NASA
Clearance Officer, NASA Headquarters,
300 E Street SW, JF0000, Washington,
DC 20546 or email claire.a.little@
nasa.gov.
khammond on DSKJM1Z7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
I. Abstract
The Electronic Health Record System
is used by the NASA Occupational
Health Program to generate records of
medical care, diagnosis, treatment,
surveillance examinations (e.g., flight
certification, special purpose and health
maintenance), and exposure records
(e.g., hazardous materials and ionizing
radiation). Management and utilization
of the Electronic Health Record System
provides necessary supportive clerical
services for the Occupational Health
Program. Occupational Health clinics
create, maintain and securely archive
digital medical records and physical
examination records of (1) NASA civil
service employees and applicants; (2)
other Agency civil service and military
employees working at NASA; (3) active
or retired astronauts and active
astronaut family members; (4)
International Space Partner personnel,
their families, or other space flight
personnel on temporary or extended
duty at NASA; (5) onsite contractor
personnel who receive job-related
examinations under the NASA
Occupational Health Program, have
work-related mishaps or accidents, or
visit clinics for emergency or first-aid
treatment; and (6) visitors to NASA
Centers who use clinics for emergency
or first-aid treatment or who apply for
use of NASA facilities. The legal
medical record is the documentation of
health care services provided to an
individual; it is used for clinical
decision making, following accurate
recording of observations, actions and
analysis of diagnostic tests. The legal
medical record in this instance is digital
recorded data collected and used for
providing healthcare at the NASA
Occupational Health clinics.
Additionally, the medical record is used
as a tool for evaluating the adequacy,
appropriateness and quality of care.
Such records contain standard clinical
information resulting from physical
examinations, laboratory and other
relevant diagnostic tests, and medical
history surveys; screening examination
results; immunization records;
administration of medications
prescribed by private/personal or NASA
physicians; consultation records; and
hazardous exposure as well as other
health hazard/abatement data.
VerDate Sep<11>2014
16:53 Dec 23, 2019
Jkt 250001
NASA collects, archives, and secures
information from individuals visiting
the Occupational Health clinics
requiring routine medical examination
in compliance with the following
regulations:
• 2015 Joint Commission (JC) Standards
for Ambulatory Care IM.01.01.01,
IM.02.01.03, IM.02.02.01, IM.02.02.03
• NASA Procedural Requirements, NPR
1800.1C.
• NASA Records Retention Schedules
NRRS 1441.1
• 5 U.S.C. 552a, Privacy Act, 1974
• 42 U.S.C. 2472; 44 U.S.C. 3101; Public
Law 92–255
• NIST SP 800–53 revision 4,
Recommended Security Controls for
Federal Information Systems
• NIST SP 800–53A, Techniques and
Procedures for Verifying the
Effectiveness of Security Controls in
Federal Information Systems
• NPR 2810.1, Security of Information
Technology.
II. Methods of Collection
Electronically and optionally by
paper.
III. Data
Title: NASA Electronic Health Record
System (EHRS).
OMB Number: 2700–xxxx.
Type of review: New.
Affected Public: Individuals.
Estimated Annual Number of
Activities: 63,260.
Estimated Number of Respondents
per Activity: 1.
Annual Responses: 63,260.
Estimated Time per Response: 0.5
hours.
Estimated Total Annual Burden
Hours: 31,630.
Estimated Total Annual Cost:
$819,217.00.
IV. Request for Comments
Comments are invited on: (1) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of NASA, including
whether the information collected has
practical utility; (2) the accuracy of
NASA’s estimate of the burden
(including hours and cost) of the
proposed collection of information; (3)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on respondents, including automated
collection techniques or the use of other
forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the request for OMB
approval of this information collection.
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
They will also become a matter of
public record.
Cheryl Parker,
NASA Federal Liaison Officer.
[FR Doc. 2019–27776 Filed 12–23–19; 8:45 am]
BILLING CODE 7510–13–P
EXECUTIVE OFFICE OF THE
PRESIDENT
Office of National Drug Control Policy
Submission for Review: Survey on the
Treatment of Opioid Use Disorders;
Correction
Office of National Drug Control
Policy, Executive Office of the
President.
AGENCY:
30-Day notice and request for
comments; correction.
ACTION:
The Office of National Drug
Control Policy published a document in
the Federal Register on December 12,
2019 concerning the Paperwork
Reduction Act; Proposed Collection;
Comment Request. The document
contained an incorrect address and
contact information.
SUMMARY:
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register of December
12, 2019 84 FR 67963, correct the
ADDRESSES caption to read:
Interested persons are
invited to submit written comments on
the proposed information collection to
the Office of Information and Regulatory
Affairs, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503, Attention: Desk
Officer for the Office of National Drug
Control Policy or sent via electronic
mail to oira_submission@omb.eop.gov
or faxed to (202) 395–6974.
ADDRESSES:
Correction
In the Federal Register of December
12, 2019 84 FR 67963, correct the FOR
FURTHER INFORMATION CONTACT caption
to read:
A
copy of this ICR, with applicable
supporting documentation, may be
obtained by contacting the Office of
Information and Regulatory Affairs,
Office of Management and Budget, 725
17th Street NW, Washington, DC 20503,
Attention: Desk Officer for the Office of
National Drug Control Policy or sent via
electronic mail oira_submission@
omb.eop.gov or faxed to (202) 395–6974.
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\26DEN1.SGM
26DEN1
Federal Register / Vol. 84, No. 247 / Thursday, December 26, 2019 / Notices
Dated: December 18, 2019.
Michael Passante,
Acting General Counsel.
NUCLEAR REGULATORY
COMMISSION
[NRC–2019–0158]
[FR Doc. 2019–27708 Filed 12–23–19; 8:45 am]
BILLING CODE 3280–F5–P
EXECUTIVE OFFICE OF THE
PRESIDENT
Office of National Drug Control Policy
Submission for Review: Survey on
Practices and Policies Related to the
Treatment of Opioid Use Disorders;
Correction
Office of National Drug Control
Policy.
ACTION: 30-Day Notice and request for
comments; correction
The Office of National Drug
Control Policy published a document in
the Federal Register on December 12,
2019 concerning the Paperwork
Reduction Act; Proposed Collection;
Comment Request. The document
contained an incorrect address and
contact information.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Correction
In the Federal Register of December
12, 2019 84 FR 67964, correct the
ADDRESSES caption to read:
ADDRESSES: Interested persons are
invited to submit written comments on
the proposed information collection to
the Office of Information and Regulatory
Affairs, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503, Attention: Desk
Officer for the Office of National Drug
Control Policy or sent via electronic
mail to oira_submission@omb.eop.gov
or faxed to (202) 395–6974.
khammond on DSKJM1Z7X2PROD with NOTICES
Correction
In the Federal Register of December
12, 2019 84 FR 67964, correct the FOR
FURTHER INFORMATION caption to read:
FOR FURTHER INFORMATION CONTACT: A
copy of this ICR, with applicable
supporting documentation, may be
obtained by contacting the Office of
Information and Regulatory Affairs,
Office of Management and Budget, 725
17th Street NW, Washington, DC 20503,
Attention: Desk Officer for the Office of
National Drug Control Policy or sent via
electronic mail oira_submission@
omb.eop.gov or faxed to (202) 395–6974.
[FR Doc. 2019–27709 Filed 12–23–19; 8:45 am]
BILLING CODE 3280–F5–P
VerDate Sep<11>2014
16:53 Dec 23, 2019
Jkt 250001
Nuclear Regulatory
Commission.
ACTION: Notice of submission to the
Office of Management and Budget;
request for comment.
AGENCY:
AGENCY:
Dated: December 18, 2019.
Michael Passante,
Acting General Counsel.
Information Collection: NRC Form 327,
Special Nuclear Material and Source
Material Physical Inventory Summary
Reports, and NUREG/BR–0096,
Instructions and Guidance for
Completing Physical Inventory
Summary Reports
The U.S. Nuclear Regulatory
Commission (NRC) has recently
submitted a request for renewal of an
existing collection of information to the
Office of Management and Budget
(OMB) for review. The information
collection is entitled, ‘‘NRC Form 327,
Special Nuclear Material and Source
Material Physical Inventory Summary
Reports, and NUREG/BR–0096,
Instructions and Guidance for
Completing Physical Inventory
Summary Reports.’’
DATES: Submit comments by January 27,
2020. Comments received after this date
will be considered if it is practical to do
so, but the Commission is able to ensure
consideration only for comments
received on or before this date.
ADDRESSES: Submit comments directly
to the OMB reviewer at: OMB Office of
Information and Regulatory Affairs
(3150–0139), Attn: Desk Officer for the
Nuclear Regulatory Commission, 725
17th Street, NW Washington, DC 20503;
email: oira_submission@omb.eop.gov.
FOR FURTHER INFORMATION CONTACT:
David Cullison, NRC Clearance Officer,
U.S. Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–2084; email:
INFOCOLLECTS.Resource@nrc.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Obtaining Information and
Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC–2019–
0158 when contacting the NRC about
the availability of information for this
action. You may obtain publiclyavailable information related to this
action by any of the following methods:
• Federal Rulemaking Website: Go to
https://www.regulations.gov and search
for Docket ID NRC–2019–0158. A copy
of the collection of information and
related instructions may be obtained
without charge by accessing Docket ID
NRC–2019–0158 on this website.
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
71005
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘Begin Web-based ADAMS Search.’’ For
problems with ADAMS, please contact
the NRC’s Public Document Room (PDR)
reference staff at 1–800–397–4209, 301–
415–4737, or by email to pdr.resource@
nrc.gov. A copy of the collection of
information and related instructions
may be obtained without charge by
accessing ADAMS Accession
ML19161A296 and ML082620258. The
supporting statement is available in
ADAMS under Accession No.
ML19318C417.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
• NRC’s Clearance Officer: A copy of
the collection of information and related
instructions may be obtained without
charge by contacting the NRC’s
Clearance Officer, David Cullison,
Office of the Chief Information Officer,
U.S. Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–2084; email:
INFOCOLLECTS.Resource@NRC.GOV.
B. Submitting Comments
The NRC cautions you not to include
identifying or contact information in
comment submissions that you do not
want to be publicly disclosed in your
comment submission. All comment
submissions are posted at https://
www.regulations.gov and entered into
ADAMS. Comment submissions are not
routinely edited to remove identifying
or contact information.
If you are requesting or aggregating
comments from other persons for
submission to the OMB, then you
should inform those persons not to
include identifying or contact
information that they do not want to be
publicly disclosed in their comment
submission. Your request should state
that comment submissions are not
routinely edited to remove such
information before making the comment
submissions available to the public or
entering the comment into ADAMS.
II. Background
Under the provisions of the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35), the NRC recently
submitted a request for renewal of an
existing collection of information to
OMB for review entitled, ‘‘NRC Form
327, Special Nuclear Material and
E:\FR\FM\26DEN1.SGM
26DEN1
]]>Agencies
[Federal Register Volume 84, Number 247 (Thursday, December 26, 2019)]
[Notices]
[Pages 71004-71005]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27708]
=======================================================================
-----------------------------------------------------------------------
EXECUTIVE OFFICE OF THE PRESIDENT
Office of National Drug Control Policy
Submission for Review: Survey on the Treatment of Opioid Use
Disorders; Correction
AGENCY: Office of National Drug Control Policy, Executive Office of the
President.
ACTION: 30-Day notice and request for comments; correction.
-----------------------------------------------------------------------
SUMMARY: The Office of National Drug Control Policy published a
document in the Federal Register on December 12, 2019 concerning the
Paperwork Reduction Act; Proposed Collection; Comment Request. The
document contained an incorrect address and contact information.
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register of December 12, 2019 84 FR 67963, correct
the Addresses caption to read:
ADDRESSES: Interested persons are invited to submit written comments on
the proposed information collection to the Office of Information and
Regulatory Affairs, Office of Management and Budget, 725 17th Street
NW, Washington, DC 20503, Attention: Desk Officer for the Office of
National Drug Control Policy or sent via electronic mail to
[email protected] or faxed to (202) 395-6974.
Correction
In the Federal Register of December 12, 2019 84 FR 67963, correct
the For Further Information Contact caption to read:
FOR FURTHER INFORMATION CONTACT: A copy of this ICR, with applicable
supporting documentation, may be obtained by contacting the Office of
Information and Regulatory Affairs, Office of Management and Budget,
725 17th Street NW, Washington, DC 20503, Attention: Desk Officer for
the Office of National Drug Control Policy or sent via electronic mail
[email protected] or faxed to (202) 395-6974.
[[Page 71005]]
Dated: December 18, 2019.
Michael Passante,
Acting General Counsel.
[FR Doc. 2019-27708 Filed 12-23-19; 8:45 am]
BILLING CODE 3280-F5-P
